You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
聯易融科技-W(09959.HK)擬1.12億元出售國藥融匯(上海)商業保理19.608%股權
格隆匯 11-22 19:04

格隆匯11月22日丨聯易融科技-W(09959.HK)公吿,於2023年11月22日,Linklogis Hong Kong Limited("賣方")(公司的全資附屬公司)、國藥控股(中國)融資租賃有限公司("買方")及其他賣方訂立股權轉讓協議,據此(其中包括),賣方有條件地同意出售及買方有條件地同意收購國藥融匯(上海)商業保理有限公司(目標公司)的19.608%股權,代價為人民幣1.12億元。

目標公司主要為醫藥及健康相關行業提供供應鏈融資服務。公司於2018年向目標公司注資並獲得其少數股權,旨在藉着目標公司與國藥集團旗下成員公司及醫藥行業的領先參與者的廣泛人脈,滲入醫藥行業的供應鏈金融場景及豐富集團所提供的供應鏈金融科技解決方案。多年來,公司透過與目標公司建立穩定及鞏固的合作關係,實現了投資目的。

近期,目標公司除其現有的醫藥健康相關產業業務外,亦在戰略上專注於為集團內上游及下游公司提供服務。買方與目標公司屬於同一集團,因此提出收購賣方及其他賣方所持有目標公司的全部股權,屆時目標公司將成為買方的全資附屬公司。

監於上文所述,董事認為聯易融出售事項將為集團帶來變現其投資及重新分配資源以作未來業務發展的良機。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account